Ken is a registered US Patent Agent with broad technical expertise in molecular biology, neuroscience, stem cells, drug discovery platforms, antibodies, small molecule therapeutic methods and cancer therapeutics.
Having worked in a number of leading US law firms, Ken’s skills include preparation, prosecution and strategic counselling for biotechnology patent portfolio growth, while also assisting clients with evaluating patent validity, freedom to operate and due diligence matters.
His knowledge in drafting and prosecuting US and foreign patent applications, several of which covered high profile therapeutic platforms licensed to large, international corporations, means that he is well aware of the importance of intellectual property rights to an organisation’s corporate balance sheet.
Years of experience in managing patent portfolios and patent applications in the US has allowed Ken to develop a real understanding of clients IP needs, and allows him to assist clients to best utilise their Intellectual Property rights as part of their business plan. This work has been across multiple biotechnology areas, including stem cells, phenotypic drug screening platforms, recombinant protein therapeutics, small molecule therapeutic methods and diagnostic methods.
Prior to joining the patent profession, Ken was a postdoctoral fellow at Cold Spring Harbor Laboratory, with Roberto Malinow, where he studied the role of glutamate receptor trafficking in synaptic plasticity using a combination of electrophysiology, molecular biology, and imaging.